Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals

Clin Transl Med. 2021 Nov;11(11):e586. doi: 10.1002/ctm2.586.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Clopidogrel / metabolism
  • Clopidogrel / pharmacology
  • Cytochrome P-450 CYP2C19 / drug effects
  • Cytochrome P-450 CYP2C19 / genetics
  • Cytochrome P-450 CYP2C9 / drug effects
  • Cytochrome P-450 CYP2C9 / genetics
  • Humans
  • Pharmacogenomic Testing / methods
  • Pharmacogenomic Testing / statistics & numerical data*
  • Precision Medicine / instrumentation
  • Precision Medicine / methods
  • Precision Medicine / trends
  • Vitamin K Epoxide Reductases / drug effects
  • Vitamin K Epoxide Reductases / genetics
  • Warfarin / metabolism
  • Warfarin / pharmacology

Substances

  • Warfarin
  • Clopidogrel
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases